Entering text into the input field will update the search result below

Merit Medical wins FDA’s breakthrough designation for pain relief therapy

Mar. 07, 2022 9:47 AM ETMerit Medical Systems, Inc. (MMSI)By: Dulan Lokuwithana, SA News Editor

Headquarters of US Food and Drug Administration (FDA)

Grandbrothers/iStock Editorial via Getty Images

  • Merit Medical (MMSI -1.1%), a company focused on disposable medical devices, announced on Monday that the U.S. Food & Drug Administration (FDA) granted its “breakthrough device designation” for Embosphere Microspheres for the Genicular Artery Embolization (GAE) indication.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.